• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, April 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Wake Forest Baptist awarded $1.6 million to test iPad colon cancer screening app

Bioengineer by Bioengineer
July 1, 2019
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

WINSTON-SALEM, N.C. – July 1, 2019 – Doctors know that screening for colorectal cancer reduces mortality. However, more than one-third of age-eligible Americans go unscreened every year even though colon cancer remains the second leading cause of cancer death in the United States.

In an effort to increase colorectal screenings, doctors at Wake Forest Baptist Health developed a specially designed iPad application that allows patients to order a colon cancer screening test while waiting at the doctor’s office before a routine primary care visit.

Called mobile Patient Technology for Health-CRC (mPATH-CRC), the iPad app informs patients of their need for screening, helps them make a screening decision, lets them “self-order” a screening test and sends automated electronic messages to help them complete their chosen test.

Findings from a previous randomized trial of 450 patients published in the April 2018 edition of the journal Annals of Internal Medicine showed that use of the mPATH-CRC app doubled the proportion of patients who completed their colorectal screening.

Now thanks to a $1.6 million grant from the National Cancer Institute, mPATH-CRC will be tested in 28 primary care clinics in North Carolina and Kentucky.

“While hundreds of mobile health apps have been developed in recent years, the best strategies for incorporating apps in routine primary care remain unknown,” said the study’s principal investigator, David Miller, M.D., professor of internal medicine at Wake Forest Baptist Health.

“Patients often have down time while they are waiting for their doctor. Our mPATH-CRC app makes good use of that currently wasted time by empowering patients with the tools and information they need to get the colorectal cancer screening test that is right for them,” Miller said.

This five-year project is designed to determine the optimal way to implement mPATH-CRC and other technology-based programs in community-based primary care practices, increasing the use of life-saving screening tests and improving the delivery of medical care.

###

Media Contact
Marguerite Beck
[email protected]

Tags: cancerMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Robotic Bronchoscopy: A Safer, Faster Breakthrough in Lung Cancer Diagnosis

April 1, 2026

Massey Pioneers New Therapeutic Standard for Stage III Colon Cancer Patients

April 1, 2026

First-in-Class Radio-Theranostic Developed Using Novel Antibody from UT MD Anderson

April 1, 2026

Targeted Therapies Enhance Long-Term Survival in Lung Cancer Patients with Rare Genetic Mutations

April 1, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1007 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Suicide Myths and Preparedness in Swedish Care Staff

Hydrogel with AAV8-sTβRII Reduces Skin Scars

Interpretable AI Boosts Cardiovascular Disease Diagnosis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.